Objective To develop response criteria for adult dermatomyositis (DM) and polymyositis
(PM). Methods Expert surveys, logistic regression, and conjoint analysis were used to …

The management of patients with idiopathic inflammatory myopathy (IIM) remains a
challenge given the systemic features beyond active myositis. That is, recognizing the …

As treatment of refractory idiopathic inflammatory myopathies (IIM) has been challenging,
there is growing interest in assessing new therapies that target various pathways implicated …

Abstract Objective Idiopathic inflammatory myopathies (IIMs) cause proximal muscle
weakness, which affects the ability to carry out the activities of daily living. Wearable physical …

Despite the lack of placebo-controlled trials, glucocorticoids are considered the mainstay of
initial treatment for idiopathic inflammatory myopathy and myositis-associated interstitial …

Despite the lack of placebo-controlled trials, glucocorticoids are considered the mainstay of
initial treatment for idiopathic inflammatory myopathy (IIMs) and myositis-associated ILD (MA …

The 213th ENMC International Workshop,“Outcome measures and clinical trial readiness in
idiopathic inflammatory myopathies (IIM),” took place in Heemskerk, The Netherlands, on …

Further research is required to evaluate the role of newer therapies such as tocilizumab (anti-
interleukin-6), abatacept (inhibition of T-cell costimulation), sifalimumab (anti-interferonα) …

Novel classification schemes for idiopathic inflammatory myopathy are based on serologic
and histopathologic features. The presence of specific myositis autoantibodies may …

Objective. Develop response criteria for juvenile dermatomyositis (JDM). Methods. We
analyzed the performance of 312 definitions that used core set measures (CSM) from either …